Key facts
- This page summarizes Ann D. Rhoads's Form 4 filing for Repare Therapeutics Inc. (RPTX).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 20 Jun 2024, 16:35.
Ann D. Rhoads - 17 Jun 2024 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)
- Role
- Director
- Signature
- /s/ Steve Forte, Attorney-in-Fact
- Issuer symbol
- RPTX
- Transactions as of
- 17 Jun 2024
- Net transaction value
- $0
- Form type
- 4
- Filing time
- 20 Jun 2024, 16:35:19 UTC
- Previous filing
- 13 Jun 2024
- Next filing
- 17 Sep 2024
- SEC filing
- View on sec.gov
Reporting owner
Issuer context
Transaction snapshot
SEC evidence
Key filing fact
Ann D. Rhoads filed Form 4 for Repare Therapeutics Inc. (RPTX) on 20 Jun 2024.
Change
- Previous filing in this sequence was filed on 13 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
RPTX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +27,200
- Change %
- Price
- $0.000000
- Shares after
- 27,200
- Date
- 17 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 27,200
- Exercise price
- $3.80
- Footnotes
- F1
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The option will vest in equal monthly installments over twelve (12) months from the date of grant, subject to Reporting Person continuing to provide service through each such date. |